ATE421583T1 - Isolierung von nukleinsäuren - Google Patents

Isolierung von nukleinsäuren

Info

Publication number
ATE421583T1
ATE421583T1 AT00929666T AT00929666T ATE421583T1 AT E421583 T1 ATE421583 T1 AT E421583T1 AT 00929666 T AT00929666 T AT 00929666T AT 00929666 T AT00929666 T AT 00929666T AT E421583 T1 ATE421583 T1 AT E421583T1
Authority
AT
Austria
Prior art keywords
substituent
sample
isolation
nucleic acids
rna
Prior art date
Application number
AT00929666T
Other languages
English (en)
Inventor
Andrew Goldsborough
Original Assignee
Cyclops Genome Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910158.6A external-priority patent/GB9910158D0/en
Priority claimed from GBGB9910154.5A external-priority patent/GB9910154D0/en
Priority claimed from GBGB9910156.0A external-priority patent/GB9910156D0/en
Priority claimed from GBGB9910157.8A external-priority patent/GB9910157D0/en
Application filed by Cyclops Genome Sciences Ltd filed Critical Cyclops Genome Sciences Ltd
Application granted granted Critical
Publication of ATE421583T1 publication Critical patent/ATE421583T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Turbine Rotor Nozzle Sealing (AREA)
  • Window Of Vehicle (AREA)
AT00929666T 1999-04-30 2000-05-02 Isolierung von nukleinsäuren ATE421583T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9910158.6A GB9910158D0 (en) 1999-04-30 1999-04-30 Isolation of nucleic acid
GBGB9910154.5A GB9910154D0 (en) 1999-04-30 1999-04-30 Polynucleotides
GBGB9910156.0A GB9910156D0 (en) 1999-04-30 1999-04-30 Polynucleotides
GBGB9910157.8A GB9910157D0 (en) 1999-04-30 1999-04-30 Polynucleotides

Publications (1)

Publication Number Publication Date
ATE421583T1 true ATE421583T1 (de) 2009-02-15

Family

ID=27451902

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00929665T ATE347616T1 (de) 1999-04-30 2000-05-02 Ribonukleinsäurederivate
AT00929666T ATE421583T1 (de) 1999-04-30 2000-05-02 Isolierung von nukleinsäuren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00929665T ATE347616T1 (de) 1999-04-30 2000-05-02 Ribonukleinsäurederivate

Country Status (6)

Country Link
US (4) US6794140B1 (de)
EP (2) EP1196631B1 (de)
AT (2) ATE347616T1 (de)
AU (4) AU4588000A (de)
DE (2) DE60032235T2 (de)
WO (4) WO2000075306A2 (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
AU4588000A (en) 1999-04-30 2000-12-28 Cyclops Genome Sciences Limited Polynucleotides
US6677120B2 (en) * 2001-03-30 2004-01-13 Isis Pharmaceuticals, Inc. Building blocks for the solution phase synthesis of oligonucleotides
US20060009409A1 (en) * 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
EP2213737B1 (de) 2002-02-01 2012-11-07 Life Technologies Corporation Doppelsträngige Oligonukleotide
US20040072226A1 (en) * 2002-07-03 2004-04-15 Stojanovic Milan N. Movement of multi-enzymatic nanoassemblies on recognition landscapes
US20040005568A1 (en) * 2002-07-03 2004-01-08 Stojanovic Milan N. Movement of multi-enzymatic nanoassemblies on recognition landscapes
GB0217963D0 (en) 2002-08-02 2002-09-11 Cyclops Genome Sciences Ltd Purification of nucleic acids
DE10315581B4 (de) * 2003-04-05 2007-06-28 Agilent Technologies, Inc. (n.d.Ges.d.Staates Delaware), Palo Alto Verfahren zur Qualitätsbestimmung von RNA-Proben
GB0317199D0 (en) * 2003-07-23 2003-08-27 Cyclops Genome Sciences Ltd Clean-up beads
WO2005012522A1 (en) * 2003-07-23 2005-02-10 Cyclops Genome Sciences Limited Clean-up beads
DE10344819B4 (de) * 2003-09-26 2017-06-29 Sartorius Stedim Biotech Gmbh Adsorptionsmembranen, Verfahren zur Herstellung derselben und Vorrichtungen, welche die Adsorptionsmembranen umfassen
JP5390772B2 (ja) 2004-11-05 2014-01-15 キアゲン ノース アメリカン ホールディングス， インコーポレイテッド 核酸を安定化試薬から精製するための組成物および方法
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
WO2007145940A2 (en) * 2006-06-05 2007-12-21 The University Of North Carolina At Chapel Hill High-throughput rna structure analysis
US8507200B2 (en) * 2007-02-09 2013-08-13 Northwestern University Particles for detecting intracellular targets
EP2142671A2 (de) * 2007-03-30 2010-01-13 Qiagen GmbH Modifizierte polynukleotide mit riboseringen
WO2008134077A1 (en) * 2007-04-30 2008-11-06 Archemix Corp. Metabolic profile directed aptamer medicinal chemistry
DK2160464T3 (da) * 2007-05-30 2014-08-04 Univ Northwestern Nukleinsyrefunktionaliserede nanopartikler til terapeutiske anvendelser
US9551033B2 (en) 2007-06-08 2017-01-24 Genentech, Inc. Gene expression markers of tumor resistance to HER2 inhibitor treatment
US7998967B2 (en) 2008-03-03 2011-08-16 Tosk, Incorporated Methotrexate adjuvants to reduce toxicity and methods for using the same
JP2011522552A (ja) * 2008-06-13 2011-08-04 リボックス・ゲーエムベーハー 化学的に修飾されたｒｎａの酵素的合成のための方法
CN106955360A (zh) 2008-11-24 2017-07-18 西北大学 多价rna纳米颗粒组合物
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
DK2396459T3 (en) 2009-02-13 2017-08-28 X-Chem Inc Method for preparing and screening DNA-encoded libraries
EP2272976A1 (de) * 2009-07-06 2011-01-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Differenzierung von Polynucleotid-Strängen
US20120185176A1 (en) 2009-09-30 2012-07-19 Natera, Inc. Methods for Non-Invasive Prenatal Ploidy Calling
DK2494075T3 (en) 2009-10-30 2018-07-23 Univ Northwestern TABLE-MANAGED NANOCONJUGATES
EP2333102A1 (de) * 2009-12-14 2011-06-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Identifizierung von RNA-Liganden
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
EP2572003A4 (de) 2010-05-18 2016-01-13 Natera Inc Verfahren zur nichtinvasiven pränatalen ploidiezuordnung
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
EP2388324A1 (de) 2010-05-20 2011-11-23 Siemens Healthcare Diagnostics Inc. Kontrollmaterial für Nukleinsäureteste
FR2968302B1 (fr) 2010-12-06 2012-11-30 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
WO2012088456A2 (en) 2010-12-22 2012-06-28 Natera, Inc. Methods for non-invasive prenatal paternity testing
AU2011358564B9 (en) 2011-02-09 2017-07-13 Natera, Inc Methods for non-invasive prenatal ploidy calling
DK2748357T3 (en) * 2011-09-07 2018-07-16 X Chem Inc Methods for labeling DNA-encoded libraries
US9889209B2 (en) 2011-09-14 2018-02-13 Northwestern University Nanoconjugates able to cross the blood-brain barrier
US9044738B2 (en) 2012-04-30 2015-06-02 General Electric Company Methods and compositions for extraction and storage of nucleic acids
US9480966B2 (en) 2012-04-30 2016-11-01 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
US9040675B2 (en) 2012-04-30 2015-05-26 General Electric Company Formulations for nucleic acid stabilization on solid substrates
US9040679B2 (en) 2012-04-30 2015-05-26 General Electric Company Methods and compositions for extraction and storage of nucleic acids
EA201992285A1 (ru) 2012-07-13 2020-05-31 Икс-Чем, Инк. Днк-кодированные библиотеки, содержащие связи кодирующих олигонуклеотидов, не доступные для считывания полимеразами
FR2994184B1 (fr) 2012-08-02 2017-12-08 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US9970002B2 (en) * 2012-12-12 2018-05-15 Massachusetts Institute Of Technology Compositions and methods for functional nucleic acid delivery
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US10240188B2 (en) 2013-10-07 2019-03-26 The University Of North Carolina At Chapel Hill Detection of chemical modifications in nucleic acids
EP3957749A1 (de) 2014-04-21 2022-02-23 Natera, Inc. Nachweis von tumorspezifischen mutationen in biopsien mittels sequenzierung des gesamten exoms und in zellfreien proben
PT3134506T (pt) 2014-04-25 2019-10-31 Translate Bio Inc Métodos de purificação de rna mensageiro
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
EP3209403A4 (de) * 2014-10-24 2018-09-12 Abbott Molecular Inc. Anreicherung von kleinen nukleinsäuren
KR20170078843A (ko) 2014-11-21 2017-07-07 노오쓰웨스턴 유니버시티 구형 핵산 나노입자 접합체의 서열 특이적 세포 흡수
DK3294885T3 (da) 2015-05-08 2020-08-10 Curevac Real Estate Gmbh Fremgangsmåde til at fremstille rna
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
PL4108769T3 (pl) 2015-05-29 2024-02-05 CureVac Manufacturing GmbH Sposób wytwarzania i oczyszczania rna obejmujący co najmniej jeden etap filtracji o przepływie stycznym
CN107921407B (zh) 2015-06-05 2022-07-05 格雷斯公司 生物处理吸附澄清剂及其制备和使用方法
CN108473932B (zh) 2015-09-09 2022-07-15 集联健康有限公司 用于样品收集、稳定化和保存的系统、方法和装置
US10214739B2 (en) * 2015-10-30 2019-02-26 Axagarius Gmbh & Co. Kg RNA binding solution
WO2017181202A2 (en) 2016-04-15 2017-10-19 Natera, Inc. Methods for lung cancer detection
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
EP3535274A4 (de) * 2016-11-07 2020-07-29 Nanosur LLC Post-transkriptionell chemisch modifizierte doppelsträngige rna
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
TWI882519B (zh) 2017-01-10 2025-05-01 美商集聯健康有限公司 用於收集和儲存來自受試者之血液的裝置
US10894976B2 (en) * 2017-02-21 2021-01-19 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
US11053608B2 (en) * 2017-06-16 2021-07-06 Boris Farber Combinatorial derivatives of RNA oligonucleotides
RU2020112854A (ru) 2017-11-30 2021-12-30 Арракис Терапьютикс, Инк. Фотозонды, связывающие нуклеиновые кислоты, и способы их применения
JP2021506342A (ja) 2017-12-14 2021-02-22 ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． 移植のための移植片適合性の評価
US12398389B2 (en) 2018-02-15 2025-08-26 Natera, Inc. Methods for isolating nucleic acids with size selection
FR3078977B1 (fr) * 2018-03-16 2023-03-17 Biomerieux Sa Procede d'extraction d'acides nucleiques
CA3090426A1 (en) 2018-04-14 2019-10-17 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP3980559A1 (de) 2019-06-06 2022-04-13 Natera, Inc. Verfahren zur detektion von immunzellen-dna und zur überwachung des immunsystems
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions
EP4396348A2 (de) * 2021-08-31 2024-07-10 Nanosur LLC Modifizierte dsrna-zusammensetzungen mit hohem molekulargewicht
WO2023101963A2 (en) * 2021-11-30 2023-06-08 Northwestern University Compositions for inhibiting dipeptide repeat protein-ribosomal rna interaction and uses thereof
AU2024217803A1 (en) * 2023-02-06 2025-08-21 The Board Of Trustees Of The Leland Stanford Junior University Methods and modifications for reducing innate immune responses to rna
US20250270299A1 (en) * 2024-01-31 2025-08-28 Helix Nanotechnologies Inc Methods of using compositions comprising sbi domains

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids
US5681726A (en) * 1988-09-19 1997-10-28 Stratagene Method of double stranded DNA synthesis
US5872232A (en) * 1990-01-11 1999-02-16 Isis Pharmaceuticals Inc. 2'-O-modified oligonucleotides
US5859221A (en) * 1990-01-11 1999-01-12 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5660985A (en) * 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5707796A (en) 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
JPH0813274B2 (ja) * 1990-08-13 1996-02-14 アイシス・ファーマシューティカルス・インコーポレーテッド 遺伝子発現を検出及び変調する糖修飾されたオリゴヌクレオチド
US5426180A (en) * 1991-03-27 1995-06-20 Research Corporation Technologies, Inc. Methods of making single-stranded circular oligonucleotides
US6235887B1 (en) * 1991-11-26 2001-05-22 Isis Pharmaceuticals, Inc. Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines
WO1994019012A2 (en) 1993-02-24 1994-09-01 Wang Jui H Compositions and methods of application of reactive antiviral polymers
EP0725788B1 (de) * 1993-10-27 1998-12-16 Ribozyme Pharmaceuticals, Inc. 2'-amido-und 2'-peptido-modifizierte oligonukleotide
US5700642A (en) * 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
AU3891097A (en) * 1996-07-24 1998-02-10 Michelle M. Hanna Base-protected nucleotide analogs with protected thiol groups
US5849902A (en) * 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
US20030083272A1 (en) * 1997-09-19 2003-05-01 Lahive & Cockfield, Llp Sense mrna therapy
DE19801153A1 (de) * 1998-01-14 1999-07-15 Jenne Andreas Verfahren zur Selektion von Ribozymen, die Ribonucleinsäuren in trans an 2'-OH-Gruppen kovalent modifizieren können und durch dieses Verfahren erhältliche Ribozyme
EP1073732A2 (de) 1998-04-29 2001-02-07 Ribozyme Pharmaceuticals, Inc. Nukleosid-triphosphate und deren einschläusung in ribozyme
EP1100830B1 (de) 1998-07-28 2003-10-01 Micromet AG Heterominikörper
AU4588000A (en) 1999-04-30 2000-12-28 Cyclops Genome Sciences Limited Polynucleotides
US6720144B1 (en) * 2001-06-21 2004-04-13 Quest Diagnostics Detection of clonal T-cell receptor-γ gene rearrangement by PCR/temporal temperature gradient gel electrophoresis (TTGE)
GB0217963D0 (en) * 2002-08-02 2002-09-11 Cyclops Genome Sciences Ltd Purification of nucleic acids
WO2005012522A1 (en) 2003-07-23 2005-02-10 Cyclops Genome Sciences Limited Clean-up beads

Also Published As

Publication number Publication date
US20050074753A1 (en) 2005-04-07
EP1196631B1 (de) 2006-12-06
EP1196631A1 (de) 2002-04-17
AU4589000A (en) 2000-11-17
WO2000066605A3 (en) 2001-04-26
WO2000075302A3 (en) 2001-04-26
AU4588000A (en) 2000-12-28
AU4767300A (en) 2001-12-17
DE60032235T2 (de) 2007-11-15
EP1177281A2 (de) 2002-02-06
AU4767400A (en) 2000-12-28
US20050272679A1 (en) 2005-12-08
US6794140B1 (en) 2004-09-21
WO2001094626A1 (en) 2001-12-13
US6867290B2 (en) 2005-03-15
WO2000066605A2 (en) 2000-11-09
WO2000075302A2 (en) 2000-12-14
US7244568B2 (en) 2007-07-17
EP1177281B1 (de) 2009-01-21
DE60041442D1 (de) 2009-03-12
US20030039985A1 (en) 2003-02-27
WO2000075306A3 (en) 2001-05-17
ATE347616T1 (de) 2006-12-15
DE60032235D1 (de) 2007-01-18
WO2000075306A2 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
ATE421583T1 (de) Isolierung von nukleinsäuren
EP0731174A3 (de) Verfahren zur Amplifikation von Nukleinsäuresequenzen
CA2020958A1 (en) Nucleic acid sequence amplification methods
EP1068356B8 (de) Adressierbare protein arrays
ATE236269T1 (de) Ein elektrochemiluminescenter nachweis von nukleinsäuren auf basis der selbsttragenden sequenzreplikation
ATE521718T1 (de) Prozess zur synthetisierung von nukleinsäure
SE8800864D0 (sv) Method of assaying of nucleic acids, a reagent combination and kit therefore
ATE144290T1 (de) Amplifikationsverfahren
DK0923598T3 (da) Fremstilling og anvendelse af normaliserede DNA-biblioteker
CA2230967A1 (en) Improved nucleic acid assays
ATE284891T1 (de) Isolierung von einzelsträngigen nukleinsäuren
FI883722A0 (fi) Alfa-amiderande enzymkompositioner och foerfaranden foer deras framstaellning och anvaendning.
DE69721282D1 (de) In vitro transpositionsystem unter verwendung einer modifizierten tn5 transposase
WO2000053804A3 (en) Genetic screening
DE50213370D1 (de) Mikrofluidisches extraktionsverfahren
NZ307444A (en) Polyphenol oxidase genes from lettuce and banana
EP0293079A3 (de) Chlamydia-Vakzin
SE8602416D0 (sv) Gen for ligninnedbrytning och anvendning derav
SE0001936D0 (sv) New method and device
Martínez‐Montero et al. Improved Synthesis and Isolation of 2′‐O‐Methyladenosine: Effective and Scalable Enzymatic Separation of 2′/3′‐O‐Methyladenosine Regioisomers
FR2657882B1 (fr) Fragments d'adn comprenant le gene de la 1-deshydrogenase, micro-organismes transformes par lesdits fragments et applications desdits fragments et micro-organismes.
WO1997037040A3 (en) Isolation and/or amplification of hepatitis c virus (hcv) nucleic acids from samples suspected to contain hcv
KR910012230A (ko) 이노신을 생산하는 미생물 및 그를 이용한 이노신의 제조방법
ES452083A1 (es) Un procedimiento para la obtencion de nocardicina.
MX9802979A (es) Procedimiento para la preparacion de moenomicina a.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties